TenNor Therapeutics Competitors and Similar CompaniesClear all
TenNor Therapeutics's competitors and similar companies include Eikon Therapeutics, Plexxikon and IMPACT Therapeutics.
 TenNor Therapeutics TenNor Therapeutics (丹诺医药是 ) is a company focusing on the research and development of drugs to address unmet medical needs in the area of infectious diseases. |  Eikon Therapeutics Eikon Therapeutics is a biopharmaceutical company that provides a method of drug discovery based on tracking and measuring the movement of individual proteins in live cells. |  Plexxikon Plexxikon is a company engaged in the discovery and development of novel, small molecule pharmaceuticals. |  IMPACT Therapeutics PACT Therapeutics (英派药业) is a biopharmaceutical company engaged in the discovery and development of therapeutics to treat cancer. | |
Founding Date | Founding Date 2013 | Founding Date 2019 | Founding Date 2001 | Founding Date 2009 |
Type | Type Private | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Suzhou Shi, CN HQ | Locations Millbrae, US HQ Hayward, US Jersey City, US New York, US | Locations South San Francisco, US HQ | Locations CN HQ Nanjing Shi, CN |
Employees | Employees 21 | Employees 384 | Employees 14 | Employees 4 |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 665.8m | Total funding raised N/A | Total funding raised $ 40m |
For sources of this data, please see the company profile
View Company Profiles
Eikon Therapeutics
HQ
Millbrae, US
Employees
384
Eikon Therapeutics is a biopharmaceutical company that provides a method of drug discovery based on tracking and measuring the movement of individual proteins in live cells.
View companyPlexxikon
HQ
South San Francisco, US
Plexxikon is a company engaged in the discovery and development of novel, small molecule pharmaceuticals.
View companyIMPACT Therapeutics
HQ
CN
Employees
4
PACT Therapeutics (英派药业) is a biopharmaceutical company engaged in the discovery and development of therapeutics to treat cancer.
View company